NCT02100046View on ClinicalTrials.gov

Assessment of the Effectiveness of Ethosuximide in the Treatment of Peripheral Neuropathic Pain.

PHASE2CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

January 1, 2017

Conditions
Neuropathic Traumatic PainPain NRS ≥ 4Peripheral Neuropathic PainNeuropathic Pain Diagnostic Questionnaire (DN4) ≥ 4
Interventions
DRUG

Zarontin® (ethosuximide) and Stodal®

Trial Locations (1)

63003

CHU de Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors
collaborator

Fondation Apicil

OTHER

lead

University Hospital, Clermont-Ferrand

OTHER

NCT02100046 - Assessment of the Effectiveness of Ethosuximide in the Treatment of Peripheral Neuropathic Pain. | Biotech Hunter | Biotech Hunter